PTC Therapeutics

Investors

PTC Therapeutics, Inc. is committed to serving the interests of our shareholders. This part of our website includes corporate governance documents, press releases, financial information and other documents to help shareholders better understand who we are and what we do.

NASDAQ: PTCT
18.81
- 0.22 (-1.16%)
11:27 AM ET on Aug 23, 2017
Delayed at least 20 minutes.
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue